Interim analysis from a second major trial shows success
Efficacy and safety end points met in 90 percent of patients
With launch of U.S. trials, the holy grail of leadless pacing seems near
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy